XML 89 R39.htm IDEA: XBRL DOCUMENT
v3.23.1

FINANCIAL ASSETS AND LIABILITIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Financial Assets And Liabilities |
Schedule of financial assets at amortized cost |
Schedule of financial assets at amortized cost |  |  |  |
|  | 12.31.2022 |  | 12.31.2021
Non-current |  |  |  |
Term deposit |  | 101 |  | 100
Notes receivable |  | 1 |  | 5
Total non-current |  | 102 |  | 105
Current |  |  |  |
Notes receivable |  | 8 |  | 5
Total current |  | 8 |  | 5
Schedule of financial assets at fair value through profit and loss |
Schedule of financial assets at fair value through profit and loss |  |  |  |
|  | 12.31.2022 |  | 12.31.2021
Non-current |  |  |  |
Shares |  | 27 |  | 29
Total non-current |  | 27 |  | 29
Current |  |  |  |
Government securities |  | 279 |  | 278
Corporate bonds |  | 116 |  | 19
Shares |  | 160 |  | 120
Mutual funds |  | 31 |  | 41
Total current |  | 586 |  | 458
Schedule of trade and other receivables |
Schedule of trade and other receivables |  |  |  |  |
| Note |  | 12.31.2022 |  | 12.31.2021
Non-Current |  |  |  |  |
Related parties | 16 |  | 17 |  | 23
Tax credits |  |  | 2 |  | 9
Prepaid expenses |  |  | - |  | 1
Other |  |  | 1 |  | 1
Other receivables |  |  | 20 |  | 34
Total non-current |  |  | 20 |  | 34
|  |  | 12.31.2022 |  | 12.31.2021
Current |  |  |  |  |
Receivables from MAT sales |  |  | 21 |  | 24
CAMMESA |  |  | 165 |  | 89
Receivables from oiland gas sales |  |  | 55 |  | 69
Receivables from petrochemicals sales |  |  | 62 |  | 71
Related parties | 16 |  | 5 |  | 7
Other |  |  | 3 |  | 5
Impairment of financial assets |  |  | (6) |  | (9)
Trade receivables, net |  |  | 305 |  | 256
Current |  |  |  |  |
Related parties | 16 |  | 7 |  | 8
Tax credits |  |  | 14 |  | 5
Receivables for complementary activities |  |  | - |  | 2
Prepaid expenses |  |  | 14 |  | 10
Financial credit |  |  | - |  | 10
Guarantee deposits |  |  | 27 |  | 30
Insurance to be recovered |  |  | - |  | 1
Expenses to be recovered |  |  | 15 |  | -
Receivables for acquisition of subsidiary |  |  | 7 |  | -
Receivables for sale of subsidiary and associates |  |  | 4 |  | 41
Receivables for financial instruments sale |  |  | 1 |  | 6
Argentine Natural Gas Production Promotion Plan |  |  | 32 |  | 14
Receivables for arbitration award | 15.6 |  | 37 |  | -
Other |  |  | 7 |  | 14
Other receivables, net |  |  | 165 |  | 141
Total current |  |  | 470 |  | 397
Schedule of allowance for the impairment of trade receivables |
Schedule of allowance for the impairment of trade receivables |  |  |  |  |  |  |
|  |  | 12.31.2022 |  | 12.31.2021 |  | 12.31.2020
At the beginning of the year |  |  | 9 |  | 16 |  | 68
Impairment (1) |  |  | 1 |  | 1 |  | 63
Utilization |  |  | (1) |  | - |  | (7)
Reversal of unused amounts |  |  | - |  | (6) |  | (3)
Gain on monetary position, net |  |  | (3) |  | (2) |  | (2)
Gain on monetary position, net |  |  | - |  | - |  | (28)
Reclasified to assets classified as held for sale |  |  | - |  | - |  | (75)
At the end of the year |  |  | 6 |  | 9 |  | 16
| (1) | It includes US$ 26 million corresponding to discontinued operations for fiscal year 2020. As of December 31, 2020, it includes US$ 13 million corresponding to the receivable impairment related to the exchange difference between the price of gas purchased by distributors and the price of gas recognised in distributors´s final tariffs between April 2018 and March 2019 to be assumed by the Federal Government in accordance to PEN Executive Order No. 1,053/18 (see Note 15).
Schedule of impairment of other financial assets assets |
Schedule of impairment of other financial assets assets |  |  |  |  |  |  |
|  |  | 12.31.2022 |  | 12.31.2021 |  | 12.31.2020
At the beginning of the year |  |  | - |  | - |  | 6
Impairment |  |  | - |  | - |  | 2
Reversal of unused amounts |  |  | - |  | - |  | (7)
Reclasified to assets classified as held for sale |  |  | - |  | - |  | (1)
At the end of the year |  |  | - |  | - |  | -
Schedule of cash and cash equivalents |
Schedule of cash and cash equivalents |  |  |  |  |  |  |
|  |  |  |  | 12.31.2022 |  | 12.31.2021
Banks |  |  |  |  | 11 |  | 26
Mutual funds |  |  |  |  | 95 |  | 84
Total |  |  |  |  | 106 |  | 110
Schedule of borrowings |
Schedule of borrowings |  |  |  |  |
|  |  | 12.31.2022 |  | 12.31.2021
Non-Current |  |  |  |  |
Financial borrowings |  |  | 108 |  | 58
Corporate bonds |  |  | 1,232 |  | 1,301
Total non-current |  |  | 1,340 |  | 1,359
Current |  |  |  |  |
Bank overdrafts |  |  | 59 |  | 11
Financial borrowings |  |  | 51 |  | 29
Corporate bonds |  |  | 163 |  | 39
Total current |  |  | 273 |  | 79
Total |  |  | 1,613 |  | 1,438
Schedule of changes in borrowings |
Schedule of changes in borrowings |  |  |  |  |  |  |
|  |  | 12.31.2022 |  | 12.31.2021 |  | 12.31.2020
At the beginning of the year |  |  | 1,438 |  | 1,614 |  | 1,947
Proceeds from borrowings |  |  | 308 |  | 188 |  | 353
Payment of borrowings |  |  | (143) |  | (336) |  | (300)
Accrued interest |  |  | 172 |  | 137 |  | 176
Payment of interests |  |  | (162) |  | (140) |  | (201)
Repurchase and redemption of corporate bonds |  |  | (28) |  | (3) |  | (155)
Result from exchange of corporate bonds |  |  | 14 |  | - |  | -
Result from repurchase of corporate bonds |  |  | (6) |  | - |  | (43)
Increases for incorporation (1) |  |  | 89 |  | - |  | -
Cancellation through dividend compensation |  |  | - |  | - |  | (12)
Gain on monetary position, net |  |  | - |  | - |  | (43)
Foreign currency exchange difference, net |  |  | (80) |  | (22) |  | (18)
Borrowing costs capitalized in property, plant and equipment |  |  | 11 |  | - |  | 10
Reclassified to liabilities associated to assets classified as held for sale |  |  | - |  | - |  | (100)
At the end of the year |  |  | 1,613 |  | 1,438 |  | 1,614
(1) | See Notes 5.1.3 and 5.1.5.
Schedule of borrowings composition |
Schedule of borrowings composition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Type of instrument |  | Company |  | Currency |  | Residual value |  |  | Interest |  | Rate |  | Expiration |  | Book value as of 12.31.2022
Corporate bonds (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
T Series CB |  | PAMPA |  | US$ |  | 93 |  |  | Fixed |  | 7.38% |  | Jul-23 |  | 95
Class 8 CB |  | PAMPA |  | $ |  | 18 |  |  | Variable |  | Badlar + 2% |  | Jul-23 |  | 20
Class 11 CB |  | PAMPA |  | $ |  | 122 |  |  | Variable |  | Badlar + 0% |  | Jan-24 |  | 140
Class 9 CB |  | PAMPA |  | US$ |  | 102 |  |  | Fixed |  | 9.50% |  | Dec-26 |  | 184
Class 1 CB |  | PAMPA |  | US$ |  | 501 |  |  | Fixed |  | 7.50% |  | Jan-27 |  | 616
Class 13 CB |  | PAMPA |  | US$ |  | 49 |  |  | Fixed |  | 0.00% |  | Dec-27 |  | 48
Class 3 CB |  | PAMPA |  | US$ |  | 285 |  |  | Fixed |  | 9.13% |  | Apr-29 |  | 292
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,395
Financial loans (2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 15 |  |  | Variable |  | Libor + 4.21% |  | Nov-24 |  | 16
|  | GW |  | US$ |  | 83 |  |  | Variable |  | Libor + 5.75% |  | Sep-26 |  | 85
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 101
Other financial loans (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 22 |  |  | Variable |  | SOFR + 0.35% |  | Jul-23 |  | 23
|  | PAMPA |  | US$ |  | 8 |  |  | Fixed |  | Between 9.50% and 14.50% |  | Between Jan-23 and May-23 |  | 8
|  | PAMPA |  | US$ |  | 27 |  |  | Variable |  | SOFR + 0% |  | Agu-24 |  | 27
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 58
Bank overdrafts (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | $ |  | 57 |  |  | Fixed |  | Between 54% and 54.50% |  | Jan-23 |  | 59
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 59
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,613
| (1) | Net of the following face value repurchases: US$ 113.7 million of ON 2026, US$ 146.2 million of ON 2027 and US$ 7.5 million of ON 2029.
| (2) | During the the fiscal year ended December 31, 2022, the Company took on new short-term financing with domestic financial entities, net of cancellations, for a total $ 8,618 million and import prefinancing for US$ 7.6 million. Additionally, the Company repaid at maturity two principal installments for the credit facility sponsored by FINNVERA in the amount of US$ 7.7 million and US$ 10.4 million corresponding to the credit facility subscribed between IDB Invest and Greenwind, a Company that is consolidated since acquisition of an additional 50% interest in August 2022.
| (3) | During the fiscal year ended December 31, 2022, the Company received disbursements in the amount of US$ 1.3 million under the credit facilities taken out with BNP Paribas S.A. in 2020. After the fiscal year closing, the Company repaid short-term bank loans with local financial entities for $ 10,065 million and import prefinancing for US$ 0.7 million.
Type of instrument |  | Company |  | Currency |  | Residual value |  |  | Interest |  | Rate |  | Expiration |  | Book value as of 12.31.2021
Corporate bonds (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
T Series CB |  | PAMPA |  | US$ |  | 389 |  |  | Fixed |  | 7.38% |  | Jul-23 |  | 400
Class 1 CB |  | PAMPA |  | US$ |  | 636 |  |  | Fixed |  | 7.50% |  | Jan-27 |  | 648
Class 3 CB |  | PAMPA |  | US$ |  | 293 |  |  | Fixed |  | 9.13% |  | Apr-29 |  | 292
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,340
Financial loans (2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 23 |  |  | Variable |  | Libor + 4.21% |  | May-24 |  | 23
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 23
Other financial loans (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 22 |  |  | Variable |  | Libor + 0.35% |  | Jul-22 |  | 22
|  | PAMPA |  | US$ |  | 43 |  |  | Variable |  | Libor + 0% |  | Aug-23 |  | 42
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 64
Bank overdrafts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | $ |  | 11 |  |  | Fixed |  | 33.00% |  | Jan-22 |  | 11
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,438
| (1) | Net of the following face value repurchases: US$ 110,4 million of ON 2023, US$ 114,0 million of ON 2027 and US$ 7,5 million of ON 2029.
On September 27, 2021, the Company repaid at maturity Class 6 CBs for $ 6,355 million.
| (2) | During the fiscal year ended December 31, 2021, the Company canceled short-term financing with local financial entities, net of borrowings, for $ 8,158 million. Additionally, the Company repaid at maturity two principal installments for the credit facility sponsored by FINNVERA in the amount of US$ 7.7 million.
| (3) | During the fiscal year ended December 31, 2021, the Company received disbursements in the amount of US$ 27 million under the credit facilities taken out with BNP in 2020.
Schedule of trade and other payables |
Schedule of trade and other payables |  |  |  |  |
| Note |  | 12.31.2022 |  | 12.31.2021
Non-Current |  |  |  |  |
Compensation agreements |  |  | 10 |  | 3
Finance leases liability |  |  | 10 |  | 9
Other |  |  | 1 |  | -
Other payables |  |  | 21 |  | 12
Total non-current |  |  | 21 |  | 12
Current |  |  |  |  |
Suppliers |  |  | 198 |  | 154
Customer advances |  |  | 3 |  | 4
Related parties | 16 |  | 14 |  | 15
Trade payables |  |  | 215 |  | 173
Compensation agreements |  |  | 12 |  | 2
Liability for acquisition of companies |  |  | 46 |  | -
Finance leases liability |  |  | 2 |  | 4
Other |  |  | 6 |  | 3
Other payables |  |  | 66 |  | 9
Total current |  |  | 281 |  | 182
Schedule of financial instruments |
Schedule of financial instruments |  |  |  |  |  |  |  |  |  |
As of December 31, 2022 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non financial assets/liabilities |  | Total
Assets |  |  |  |  |  |  |  |  |  |
Trade receivables and other receivables |  | 437 |  | 22 |  | 459 |  | 31 |  | 490
Financial assets at amortized cost |  |  |  |  |  |  |  |  |  |
Term deposit |  | 101 |  | - |  | 101 |  | - |  | 101
Notes receivable |  | 9 |  | - |  | 9 |  | - |  | 9
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |  |  |
Government securities |  | - |  | 279 |  | 279 |  | - |  | 279
Corporate bonds |  | - |  | 116 |  | 116 |  | - |  | 116
Shares |  | - |  | 187 |  | 187 |  | - |  | 187
Mutual funds |  | - |  | 31 |  | 31 |  | - |  | 31
Cash and cash equivalents |  | 11 |  | 95 |  | 106 |  | - |  | 106
Total |  | 558 |  | 730 |  | 1,288 |  | 31 |  | 1,319
Liabilities |  |  |  |  |  |  |  |  |  |
Trade and other liabilities |  | 298 |  | - |  | 298 |  | 4 |  | 302
Borrowings |  | 1,613 |  | - |  | 1,613 |  | - |  | 1,613
Derivative financial instruments |  | - |  | 2 |  | 2 |  | - |  | 2
Total |  | 1,911 |  | 2 |  | 1,913 |  | 4 |  | 1,917
As of December 31, 2021 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non financial assets/liabilities |  | Total
Assets |  |  |  |  |  |  |  |  |  |
Trade receivables and other receivables |  | 376 |  | 30 |  | 406 |  | 25 |  | 431
Financial assets at amortized cost |  |  |  |  |  |  |  |  |  |
Term deposit |  | 100 |  | - |  | 100 |  | - |  | 100
Notes receivable |  | 10 |  | - |  | 10 |  | - |  | 10
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |  |
Government securities |  | - |  | 278 |  | 278 |  | - |  | 278
Corporate bonds |  | - |  | 19 |  | 19 |  | - |  | 19
Shares |  | - |  | 149 |  | 149 |  | - |  | 149
Mutual funds |  | - |  | 41 |  | 41 |  | - |  | 41
Cash and cash equivalents |  | 26 |  | 84 |  | 110 |  | - |  | 110
Total |  | 512 |  | 601 |  | 1,113 |  | 25 |  | 1,138
Liabilities |  |  |  |  |  |  |  |  |  |
Trade and other liabilities |  | 190 |  | - |  | 190 |  | 4 |  | 194
Borrowings |  | 1,438 |  | - |  | 1,438 |  | - |  | 1,438
Total |  | 1,628 |  | - |  | 1,628 |  | 4 |  | 1,632
Schedule of income, expenses, gains and losses from financial instruments |
Schedule of income, expenses, gains and losses from financial instruments |  |  |  |  |  |  |  |  |  |
As of December 31, 2022 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 5 |  | - |  | 5 |  | - |  | 5
Interest expenses |  | (175) |  | - |  | (175) |  | (41) |  | (216)
Foreign currency exchange difference, net |  | 16 |  | (85) |  | (69) |  | 149 |  | 80
Changes in the fair value of financial instruments |  | - |  | 110 |  | 110 |  | - |  | 110
Result from present value measurement |  | (1) |  | - |  | (1) |  | (13) |  | (14)
Other financial results |  | (15) |  | - |  | (15) |  | - |  | (15)
Total |  | (170) |  | 25 |  | (145) |  | 95 |  | (50)
As of December 31, 2021 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 10 |  | - |  | 10 |  | - |  | 10
Interest expenses |  | (138) |  | - |  | (138) |  | (40) |  | (178)
Foreign currency exchange difference, net |  | (11) |  | (19) |  | (30) |  | 33 |  | 3
Changes in the fair value of financial instruments |  | - |  | (15) |  | (15) |  | - |  | (15)
Result from present value measurement |  | 2 |  | - |  | 2 |  | (3) |  | (1)
Other financial results |  | (4) |  | - |  | (4) |  | (4) |  | (8)
Total |  | (141) |  | (34) |  | (175) |  | (14) |  | (189)
As of December 31, 2020 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 9 |  | - |  | 9 |  | - |  | 9
Interest expenses |  | (164) |  | - |  | (164) |  | (6) |  | (170)
Foreign currency exchange difference, net |  | 38 |  | (35) |  | 3 |  | 11 |  | 14
Changes in the fair value of financial instruments |  | - |  | 30 |  | 30 |  | - |  | 30
Result from present value measurement |  | 6 |  | - |  | 6 |  | (4) |  | 2
Other financial results |  | 36 |  | - |  | 36 |  | (5) |  | 31
Total |  | (75) |  | (5) |  | (80) |  | (4) |  | (84)
Schedule of fair value of financial instruments |
Schedule of fair value of financial instruments |  |  |  |  |  |  |  |
As of December 31, 2022 |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Financial assets at fair value through profit and losss |  |  |  |  |  |  |  |
Government securities |  | 279 |  | - |  | - |  | 279
Corporate bonds |  | 116 |  | - |  | - |  | 116
Mutual funds |  | 31 |  | - |  | - |  | 31
Shares |  | 160 |  | - |  | 27 |  | 187
Cash and cash equivalents |  |  |  |  |  |  |  |
Mutual funds |  | 95 |  | - |  | - |  | 95
Other receivables |  | 22 |  | - |  | - |  | 22
Total assets |  | 703 |  | - |  | 27 |  | 730
Liabilities |  |  |  |  |  |  |  |
Derivative financial instruments |  | - |  | 2 |  | 0 |  | 2
Total liabilities |  | - |  | 2 |  | - |  | 2
As of December 31, 2021 |  | Level 1 |  | Level 3 |  | Total |  |
Assets |  |  |  |  |  |  |  |
Financial assets at fair value through profit and losss |  |  |  |  |  |  |  |
Government securities |  | 278 |  | - |  | 278 |  |
Corporate bonds |  | 19 |  | - |  | 19 |  |
Mutual funds |  | 41 |  | - |  | 41 |  |
Shares |  | 120 |  | 29 |  | 149 |  |
Cash and cash equivalents |  |  |  |  |  |  |  |
Mutual funds |  | 84 |  | - |  | 84 |  |
Other receivables |  | 30 |  | - |  | 30 |  |
Total assets |  | 572 |  | 29 |  | 601 |  |

X
- References No definition available. + Details
Name: | pam_DisclosureOfAllowanceForImpairmentOfTradeReceivablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfBorrowingsCompositionTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfBorrowingsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfChangesInBorrowingsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFairValueOfFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialAssetsAtAmortizedCostTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialAssetsAtFairValueThroughProfitAndLossTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfIncomeExpensesGainsAndLossesFromFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfOtherFinancialAssetsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfTradeAndOtherPayablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfTradeAndOtherReceivablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_FinancialAssetsAndLiabilitiesAbstract
Namespace Prefix: | pam_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration